Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Lack of TSH stimulation in patients with differentiated thyroid cancer - possible causes.

Gut P, Matysiak-Grześ M, Fischbach J, Klimowicz A, Gryczyńska M, Ruchała M.

Contemp Oncol (Pozn). 2012;16(3):273-5. doi: 10.5114/wo.2012.29299. Epub 2012 Jul 6.

PMID:
23788893
[PubMed]
Free PMC Article
2.

Follow-up of differentiated thyroid carcinoma.

Pagano L, Klain M, Pulcrano M, Angellotti G, Pasano F, Salvatore M, Lombardi G, Biondi B.

Minerva Endocrinol. 2004 Dec;29(4):161-74. Review. English, Italian.

PMID:
15765026
[PubMed - indexed for MEDLINE]
Free Article
3.

Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.

Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Rubello D, Al-Nahhas A, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M.

Biomed Pharmacother. 2007 Sep;61(8):468-71. Epub 2007 May 22.

PMID:
17553654
[PubMed - indexed for MEDLINE]
4.

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F.

Endocr Relat Cancer. 2005 Mar;12(1):49-64. Review.

PMID:
15788638
[PubMed - indexed for MEDLINE]
Free Article
5.

The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.

Pellegriti G, Scollo C, Regalbuto C, Attard M, Marozzi P, Vermiglio F, Violi MA, Cianci M, Vigneri R, Pezzino V, Squatrito S.

Clin Endocrinol (Oxf). 2003 May;58(5):556-61.

PMID:
12699436
[PubMed - indexed for MEDLINE]
6.

Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.

Mariani G, Ferdeghini M, Augeri C, Villa G, Taddei GZ, Scopinaro G, Boni G, Bodei L, Rabitti C, Molinari E, Bianchi R.

Cancer Biother Radiopharm. 2000 Apr;15(2):211-7.

PMID:
10803328
[PubMed - indexed for MEDLINE]
7.

Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?

Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.

Thyroid. 2010 Jan;20(1):15-23. doi: 10.1089/thy.2008.0416.

PMID:
20017617
[PubMed - indexed for MEDLINE]
8.

Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer.

Bombardieri E, Seregni E, Villano C, Aliberti G, Mattavelli F.

Tumori. 2003 Sep-Oct;89(5):533-6. Review.

PMID:
14870779
[PubMed - indexed for MEDLINE]
9.
10.

[The clinical use of human recombinant TSH].

Bucci I, Napolitano G, Giuliani C, Montani V, Di Vincenzo S, Monaco F.

Clin Ter. 1999 Sep-Oct;150(5):351-8. Review. Italian.

PMID:
10687266
[PubMed - indexed for MEDLINE]
11.

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.

Golger A, Fridman TR, Eski S, Witterick IJ, Freeman JL, Walfish PG.

J Endocrinol Invest. 2003 Oct;26(10):1023-31.

PMID:
14759077
[PubMed - indexed for MEDLINE]
12.

Failure of TSH rise prior to radio-iodine therapy for thyroid cancer: implications for treatment.

Nutting C, Hyer S, Vini L, Harmer C.

Clin Oncol (R Coll Radiol). 1999;11(4):269-71.

PMID:
10473725
[PubMed - indexed for MEDLINE]
13.

Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, Pacini F.

Eur J Endocrinol. 2001 Jan;144(1):5-11.

PMID:
11174831
[PubMed - indexed for MEDLINE]
Free Article
14.

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.

Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1077-86. Epub 2003 May 29.

PMID:
12783219
[PubMed - indexed for MEDLINE]
15.

[Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].

Lind P, Igerc I, Kohlfürst S.

Wien Med Wochenschr. 2005 Oct;155(19-20):429-35. German.

PMID:
16424998
[PubMed - indexed for MEDLINE]
16.

Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.

Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.

J Bone Miner Res. 2005 Mar;20(3):480-6. Epub 2004 Nov 29.

PMID:
15746993
[PubMed - indexed for MEDLINE]
17.

[Influence of the endogene TSH stimulation of thyroid volume increase in the patients after total thyroidectomy due to differentiated thyroid cancer].

Pietz L, Michałek K, Waśko R, Ruchała M, Sowiński J.

Endokrynol Pol. 2008 Mar-Apr;59(2):119-22. Polish.

PMID:
18465686
[PubMed - indexed for MEDLINE]
18.

Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer.

Ralli M, Cohan P, Lee K.

J Endocrinol Invest. 2005 Mar;28(3):270-3.

PMID:
15952413
[PubMed - indexed for MEDLINE]
19.

Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.

Krausz Y, Uziely B, Nesher R, Chisin R, Glaser B.

Isr Med Assoc J. 2001 Nov;3(11):843-9. Review.

PMID:
11729583
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk